Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)Zhijie Wang, Lei Nie, Liang Han et al.|Journal of Clinical Oncology|2022Cited by 177
AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cancerJung‐Yun Lee, Lingying Wu, Sathana Boonyapipat et al.|Gynecologic Oncology|2025Cited by 7
[Wound information management system: a standardized scheme for acquisition, storage and management of wound information].Hu Liu, Shuliang Lu, Rong-jia Su et al.|PubMed|2012Cited by 1